| Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
|---|---|---|---|---|---|---|---|
| Doxorubicin | hsa-miR-375-3p | miRNA | sensitive | High | Breast Cancer | Homo sapiens | |
| Tamoxifen | hsa-miR-375-3p | miRNA | sensitive | High | Breast Cancer | Homo sapiens | |
| Tamoxifen | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Ruthenium | hsa-miR-375-3p | miRNA | sensitive | Low | Ovarian Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-375-3p | miRNA | resistant | High | Lung Adenocarcinoma | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | resistant | Low | Cervical Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-375-3p | miRNA | resistant | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Vinorelbine | hsa-miR-375-3p | miRNA | resistant | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Oxaliplatin | hsa-miR-375-3p | miRNA | sensitive | High | Colorectal Cancer | Homo sapiens | |
| Oxaliplatin | hsa-miR-375-3p | miRNA | resistant | High | Colorectal Cancer | Homo sapiens | |
| Doxorubicin | hsa-miR-375-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
| Chemotherapy | hsa-miR-375-3p | miRNA | resistant | High | Osteosarcoma | Homo sapiens | |
| Trastuzumab | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Docetaxel | hsa-miR-375-3p | miRNA | sensitive | High | Prostate Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | resistant | High | Breast Cancer | Homo sapiens | |
| Epirubicin | hsa-miR-375-3p | miRNA | resistant | High | Breast Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | resistant | Low | Cervical Cancer | Homo sapiens | |
| Gefitinib | hsa-miR-375-3p | miRNA | resistant | High | Lung Adenocarcinoma | Homo sapiens | |
| Cisplatin | hsa-miR-375-3p | miRNA | sensitive | High | Breast Cancer | Homo sapiens | |
| Cetuximab | hsa-miR-375-3p | miRNA | resistant | High | Colon Cancer | Homo sapiens | |
| Vandetanib | hsa-miR-375-3p | miRNA | sensitive | Low | Medullary Thyroid Cancer | Homo sapiens | |
| Doxorubicin | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Tamoxifen | hsa-miR-375-3p | miRNA | resistant | High | Breast Cancer | Homo sapiens | |
| Aromatase Inhibitor | hsa-miR-375-3p | miRNA | resistant | Low | Breast Cancer | Homo sapiens | |
| Docetaxel | hsa-miR-375-3p | miRNA | resistant | Low | Prostate Cancer | Homo sapiens | |
| Tamoxifen | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | resistant | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Doxorubicin | hsa-miR-375-3p | miRNA | sensitive | Low | Hepatocellular Carcinoma | Homo sapiens | |
| Fulvestrant | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Ceritinib | hsa-miR-375-3p | miRNA | sensitive | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Ceritinib | hsa-miR-375-3p | miRNA | sensitive | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Panobinostat | hsa-miR-375-3p | miRNA | sensitive | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Gefitinib | hsa-miR-375-3p | miRNA | resistant | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | resistant | Low | Prostate Cancer | Homo sapiens | |
| Gefitinib | hsa-miR-375-3p | miRNA | resistant | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Fluorouracil | hsa-miR-375-3p | miRNA | resistant | High | Gastric Cancer | Homo sapiens | |
| Gemcitabine | hsa-miR-375-3p | miRNA | resistant | High | Pancreatic Cancer | Homo sapiens | |
| Fluorouracil | hsa-miR-375-3p | miRNA | sensitive | Low | Colorectal Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-375-3p | miRNA | sensitive | Low | Ovarian Cancer | Homo sapiens | |
| Taxane/Cisplatin/Fluorouracil | hsa-miR-375-3p | miRNA | sensitive | High | Hypopharyngeal Squamous Cell Carcinoma | Homo sapiens | |
| Fluorouracil | hsa-miR-375-3p | miRNA | sensitive | Low | Colorectal Cancer | Homo sapiens | |
| Sorafenib | hsa-miR-375-3p | miRNA | sensitive | Low | Hepatocellular Carcinoma | Homo sapiens | |
| Sorafenib | hsa-miR-375-3p | miRNA | sensitive | Low | Hepatocellular Carcinoma | Homo sapiens | |
| Cisplatin | hsa-miR-375-3p | miRNA | sensitive | Low | Osteosarcoma | Homo sapiens | |
| 4-Hydroxytamoxifen | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Doxorubicin | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-375-3p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Osimertinib | hsa-miR-375-3p | miRNA | resistant | Low | Non-Small Cell Lung Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-375-3p | miRNA | sensitive | Low | Hepatocellular Carcinoma | Homo sapiens | |
| Chidamide | hsa-miR-375-3p | miRNA | sensitive | High | Lung Squamous Cell Carcinoma | Homo sapiens | |
Network
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
